David Roth recently retired from Blackstone, with whom he was a Senior Managing Director in the firm?s Real Estate group and served as the head of Latin America investments, based in New York. Before joining Blackstone, David was a Principal in the acquisitions group at Walton Street Capital. Early in his career, David ran acquisitions in Europe for Security Capital Group and was an associate attorney at Wachtell, Lipton, Rosen & Katz.
In February 2010, as a healthy 43 year old, David became acutely ill. Like many sufferers of Lyme disease, he didn’t see a Lyme rash and didn’t know what symptoms to look for. David went to a dozen of the best doctors who didn’t know the symptoms of tick-borne disease and who relied upon faulty diagnostic tests. He received two negative blood tests before a CDC positive test, four months after becoming ill. After nearly four months of medical visits and misdiagnoses, he was ultimately diagnosed as suffering from Lyme disease and Babesia. David was treated on and off for a year with antibiotics, anti-malarials (for the Babesia) and a variety of other drugs, supplements and dietary changes. After two and a half years of illness, he finally reached the level of wellness where he currently sits – about 85% of the human he was before he got ill. David continues to suffer periodic bouts of his original symptoms.
In the search for meaning and in order to help solve what he saw as a grave social injustice, David became one of the founders of the Tick Borne Disease Alliance, which eventually merged with another group to become what is know today as Global Lyme Alliance, before joining the Board of Project Lyme.
David received a B.A. with a major in Government from Dartmouth College, where he graduated Phi Beta Kappa and magna cum laude. He also received a J.D. from New York University School of Law and is a Certified Financial Analyst Charterholder. He currently serves on the Board of Jazz Aspen Snowmass and the International Board of the Sao Paolo Biennale and on the National Council of the Aspen Art Museum.